(1.02%) 5 099.92 points
(0.42%) 38 245 points
(1.96%) 15 918 points
(0.41%) $83.91
(-3.24%) $1.585
(0.29%) $2 349.30
(-0.29%) $27.28
(0.22%) $922.50
(0.43%) $0.936
(0.75%) $11.03
(0.28%) $0.802
(-0.07%) $92.10
@ $105.56
発行日: 26 4月 2024 @ 02:42
リターン: 1.83%
前回のシグナル: 4月 25 - 22:30
前回のシグナル:
リターン: -1.79 %
Live Chart Being Loaded With Signals
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally...
Stats | |
---|---|
本日の出来高 | 612 914 |
平均出来高 | 3.78M |
時価総額 | 41.16B |
EPS | $0 ( 2024-02-22 ) |
次の収益日 | ( $-3.59 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.72 |
ATR14 | $2.76 (2.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Afeyan Noubar | Sell | 8 243 | Common Stock |
2024-04-17 | Afeyan Noubar | Sell | 6 475 | Common Stock |
2024-04-17 | Afeyan Noubar | Sell | 282 | Common Stock |
2024-04-15 | Hoge Stephen | Sell | 15 000 | Common Stock |
2024-04-10 | Afeyan Noubar | Sell | 6 351 | Common Stock |
INSIDER POWER |
---|
31.48 |
Last 100 transactions |
Buy: 525 652 | Sell: 276 824 |
ボリューム 相関
Moderna Inc 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Moderna Inc 相関 - 通貨/商品
Moderna Inc 財務諸表
Annual | 2023 |
収益: | $6.75B |
総利益: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2023 |
収益: | $6.75B |
総利益: | $2.06B (30.52 %) |
EPS: | $-12.34 |
FY | 2022 |
収益: | $19.26B |
総利益: | $13.85B (71.88 %) |
EPS: | $21.22 |
FY | 2021 |
収益: | $18.47B |
総利益: | $15.85B (85.83 %) |
EPS: | $30.31 |
Financial Reports:
No articles found.
Moderna Inc
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。